[Translation] A randomized, double-blind, placebo-controlled, dose-escalation phase I study to observe the safety, tolerability, pharmacokinetic characteristics, and food effects of WX0005 tablets
主要目的: 观察人体对不同剂量组口服WX0005片在健康人体内的安全性和耐受性。 次要目的: 考察单次和多次连续口服WX0005片在健康人体内的药代动力学特征。 观察食物对WX0005片药代动力学的影响。
[Translation] Primary objective: To observe the safety and tolerability of oral administration of WX0005 tablets in healthy humans at different doses. Secondary objective: To investigate the pharmacokinetic characteristics of WX0005 tablets in healthy humans after single and multiple oral administrations. To observe the effect of food on the pharmacokinetics of WX0005 tablets.